
The $1.78 million fund by Cancer Council Queensland for research done to diagnose, treat and prevent cancer at the University of Queensland is a boon for the researchers.
Prof. Robyn Ward, UQ Deputy Vice-Chancellor (Research) and Vice President (Research) congratulated the successful research teams and thanked Cancer Council Queensland for its generous support.
Advertisement
Nine research projects designed to develop better ways to prevent, treat and diagnose acute myeloid leukaemias and cancers of the breast, ovaries, testicles, prostate, skin and brain will be benefited by the grants.
Professor Ward said, "As a clinical oncologist and bowel cancer researcher myself, I know how important these grants are to helping our scientists develop their ideas into outcomes that will improve the future health of Queenslanders. Cancer Council Queensland and its supporters have a proud history of investing in the state's leading cancer researchers, and we are delighted to count our researchers among them."
Cancer Council Queensland spokesperson Katie Clift said, the organisation was proud to be funding ground-breaking research projects at The University of Queensland.
"It's crucial that we fund more research to discover better treatments for Queenslanders diagnosed with cancer. We are confident in the work of the University of Queensland and their contribution to clinical research, making a real difference to treatments and outcomes of Queenslanders diagnosed with cancer. Their research is world-leading and very promising. We look forward to seeing the results of these projects in the future," Clift said.
Source: Medindia
Advertisement
Cancer Council Queensland spokesperson Katie Clift said, the organisation was proud to be funding ground-breaking research projects at The University of Queensland.
"It's crucial that we fund more research to discover better treatments for Queenslanders diagnosed with cancer. We are confident in the work of the University of Queensland and their contribution to clinical research, making a real difference to treatments and outcomes of Queenslanders diagnosed with cancer. Their research is world-leading and very promising. We look forward to seeing the results of these projects in the future," Clift said.
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News

Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.

HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.

The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.

Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.

The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.